On May 3, the Drug Enforcement Administration (DEA) issued a statement from Administrator Anne Milgram on COVID-19 telemedicine flexibilities for prescribing controlled substances in which the DEA noted that it has “decided...more
This week, the House voted overwhelmingly in support of the Advancing Telehealth Beyond COVID-19 Act of 2022 (H.R. 4040). The legislation targets many of the key temporary Medicare telehealth flexibilities that are currently...more
After weeks of negotiations and months of temporary stopgap funding bills since the federal fiscal year started in October 2021, on Tuesday, the President signed the Consolidated Appropriations Act, 2022, an omnibus funding...more
3/17/2022
/ Biden Administration ,
Controlled Substances ,
Federal Funding ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Medicare ,
New Legislation ,
Section 340B ,
Telehealth
As the Biden administration begins its second year in office, the administration remains focused on its core health policy agenda—advancing coverage, access and equity....more
2/4/2022
/ Biden Administration ,
Coronavirus/COVID-19 ,
Drug Pricing ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Infectious Diseases ,
Medicaid ,
Medicare ,
Public Health Insurance Marketplace ,
Surprise Medical Bills ,
Telehealth